Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1

Br J Pharmacol. 2003 May;139(2):362-7. doi: 10.1038/sj.bjp.0705261.

Abstract

1 Patch clamp recordings were made from periaqueductal grey (PAG) neurons in vitro to investigate the cellular actions of opioids in wild-type C57B16/J mice and mutant mice lacking the first exon of the micro -opioid (MOP) receptor. 2 In wild-type mice, the kappa-(KOP) agonist U-69593 (300 nM) and the mixed micro /delta-opioid agonist met-enkephalin (10 micro M), but not the delta-(DOP) agonist deltorphin (300 nM), reduced the amplitude of evoked GABA(A)-mediated inhibitory postsynaptic currents (IPSCs). Met-enkephalin and U-69593 also reduced the rate of spontaneous miniature IPSCs, but had no effect on their amplitude and kinetics. In micro -receptor-deleted mice, only U-69593 (300 nM) reduced the amplitude of evoked IPSCs. 3 In wild-type mice, the MOP agonist DAMGO (3 micro M) produced an outward current in 76% of the neurons. Deltorphin and U-69593 produced outward currents in 24 and 32% of the neurons, respectively. In micro -receptor-deleted mice, deltorphin and U-69593 produced similar outward currents in 32 and 27% of the neurons, respectively, while DAMGO was without effect. All neurons in both the wild-type and micro -receptor-deleted mice responded with similar outward currents to either the GABA(B) receptor agonist baclofen (10 micro M), or the opioid-like receptor ORL1 (NOP) agonist nociceptin (300 nM). 4 The DAMGO-, deltorphin-, U-69593-, baclofen- and nociceptin-induced currents displayed inward rectification and reversed polarity at -109 to -116 mV. 5 These findings indicate that micro -, delta- and kappa-opioid receptor activation has complex pre- and postsynaptic actions within the mouse PAG. This differs to the rat PAG where only micro -opioid receptor actions have been observed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Animals
  • Benzeneacetamides / pharmacology
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • Enkephalin, Methionine / pharmacology
  • Female
  • GABA-A Receptor Antagonists
  • In Vitro Techniques
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neurons / drug effects
  • Neurons / physiology*
  • Oligopeptides / pharmacology
  • Patch-Clamp Techniques
  • Periaqueductal Gray / drug effects
  • Periaqueductal Gray / physiology*
  • Potassium Channels, Inwardly Rectifying / physiology
  • Pyrrolidines / pharmacology
  • Receptors, GABA-A / physiology*
  • Receptors, Opioid, delta / agonists
  • Receptors, Opioid, delta / physiology
  • Receptors, Opioid, kappa / agonists
  • Receptors, Opioid, kappa / physiology
  • Receptors, Opioid, mu / agonists*
  • Receptors, Opioid, mu / genetics
  • Receptors, Opioid, mu / physiology
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Analgesics, Opioid
  • Benzeneacetamides
  • GABA-A Receptor Antagonists
  • Oligopeptides
  • Potassium Channels, Inwardly Rectifying
  • Pyrrolidines
  • Receptors, GABA-A
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • deltorphin
  • Enkephalin, Methionine
  • U 69593